Acyclovir has not been shown to impair fertility in humans at standard prescribed doses. It is widely used during pregnancy and around the time of conception, and major health guidelines do not list infertility as a concern. However, animal studies using high doses have raised questions about potential effects on male reproductive hormones and sperm, so the topic deserves a closer look.
What Animal Studies Show
Most of the concern about acyclovir and fertility comes from animal research, not human data. A study in male Wistar rats found that high-dose acyclovir (40 mg/kg body weight) significantly reduced levels of key reproductive hormones. Testosterone dropped by roughly 60%, while follicle-stimulating hormone (FSH, which drives sperm production) fell by about 30%, and luteinizing hormone (LH, which signals testosterone production) dropped by about 35%. These changes were accompanied by signs of oxidative stress and inflammation in testicular tissue.
Importantly, the lower dose in that study (10 mg/kg) did not produce statistically significant hormone changes. This matters because the high dose used in rats is proportionally much larger than what humans typically take. A standard oral dose for herpes suppression is 400 mg two or three times daily, which works out to a fraction of the high dose used in these animal experiments when adjusted for body weight. Animal studies use exaggerated doses deliberately to identify potential toxicity, so these findings signal something worth monitoring rather than a confirmed risk in people.
Why Acyclovir Is Considered Safe for Human Cells
Acyclovir works by mimicking a building block of DNA. Once inside a virus-infected cell, it gets converted into its active form and jams the machinery the virus uses to copy its genetic material. The key to its safety profile is selectivity: it targets the viral version of this copying machinery far more effectively than the human version. Studies of a closely related compound found that the concentration needed to interfere with human DNA replication enzymes was 35 to 50 times higher than the concentration needed to block the viral enzyme.
This selectivity explains why acyclovir can attack an active herpes infection without doing significant damage to your own dividing cells, including the cells involved in producing eggs and sperm. At therapeutic doses, the drug reaches concentrations high enough to shut down viral replication but far too low to meaningfully disrupt human cell division.
Acyclovir Use Around Conception and Pregnancy
The CDC’s 2021 STI treatment guidelines note that many pregnancies have been exposed to acyclovir and that the drug is considered safe during all three trimesters. It is also considered safe during breastfeeding. For women with recurrent genital herpes, suppressive therapy starting at 36 weeks of gestation is a standard recommendation to reduce the chance of an active outbreak at delivery.
One case-control study flagged a possible association between antiviral use around conception (from one month before through the first three months of pregnancy) and a rare birth defect called gastroschisis, where the baby’s intestines develop outside the abdomen. This outcome is uncommon to begin with, and a single observational study cannot prove the drug caused it. Still, the finding is noted in clinical guidelines as something clinicians are aware of.
No major medical organization, including the CDC or the American College of Obstetricians and Gynecologists, advises stopping acyclovir when trying to conceive. The drug does not appear in lists of medications known to impair female or male fertility in humans.
What This Means for Men Trying to Conceive
The animal data on testosterone and sperm-related hormones naturally raises questions for men on long-term suppressive acyclovir therapy. There are no large human studies specifically measuring sperm counts or hormone levels in men taking standard acyclovir doses over months or years. The absence of reported fertility problems in decades of widespread clinical use is reassuring, but it is not the same as definitive proof of zero effect.
If you are a man taking daily acyclovir and have been having difficulty conceiving, a semen analysis is a straightforward first step that can identify whether sperm count, motility, or morphology are contributing factors. Testosterone and other hormone levels can also be checked with a simple blood draw. These tests would pick up the kind of changes seen in the high-dose animal studies if they were occurring in your body.
What This Means for Women Trying to Conceive
There is no evidence that acyclovir interferes with ovulation, egg quality, or implantation. The drug’s safety record in pregnancy suggests it does not disrupt the hormonal environment needed for conception or early fetal development. Women taking acyclovir to suppress herpes outbreaks are generally advised to continue their regimen while trying to conceive, since an active herpes outbreak during pregnancy or delivery poses its own risks.
The herpes virus itself, rather than the medication used to manage it, is the more relevant concern for reproductive planning. Suppressive therapy reduces the frequency and severity of outbreaks, lowers the risk of transmitting the virus to a partner, and protects newborns from exposure during delivery. Stopping the medication to avoid a theoretical fertility risk could introduce a more concrete one.